<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="367418">
  <stage>Registered</stage>
  <submitdate>12/11/2014</submitdate>
  <approvaldate>25/11/2014</approvaldate>
  <actrnumber>ACTRN12614001233617</actrnumber>
  <trial_identification>
    <studytitle>Does the bubble­-positive expiratory pressure (PEP) device improve secretion clearance compared to the active cycle of breathing technique (ACBT) or no intervention (control) in people with non­-cystic fibrosis bronchiectasis?</studytitle>
    <scientifictitle>Does the bubble­-positive expiratory pressure (PEP) device improve secretion clearance compared to the active cycle of breathing technique (ACBT) or no intervention (control) in people with non­-cystic fibrosis bronchiectasis?
</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Non-cystic fibrosis bronchiectasis</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Bubble-positive expiratory pressure (PEP) device:
Administered: Mouth-piece PEP device.
Pressure of 10-20cm H2O. 
1 cycle =  3-4 deep breaths followed by 10 repetitions of blowing into the Bubble-PEP device and then 2 huffs and coughs. Repetitive cycles for a total intervention time of 30 minutes (with rest periods as needed).

Adherence will be monitored by the physiotherapist delivering the intervention.</interventions>
    <comparator>Comparators - ACBT or no intervention
Active cycle of breathing technique (ACBT) is a self-administered breathing technique consisting of a cycle of controlled breathing, deep breathing, huffs and coughs.
Dose/intensity used: N/A.
Repetitive cycles of the ACBT for a a total intervention time of 30 minutes (with rest periods as needed).

Adherence will be monitored by the physiotherapist delivering the intervention.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Weight of sputum as measured by calibrated scales.</outcome>
      <timepoint>During 30 minutes of intervention and 60 minutes post intervention.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To evaluate the acceptability and perceived benefits of the bubble­PEP device by participants immediately post intervention. This will be measured by a 5 point Likert scale.</outcome>
      <timepoint>Immediately Post intervention</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- Confirmed diagnosis of bronchiectasis on CT
­- Reported daily sputum production
­- Ability to perform airway clearance techniques
</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>- Primary diagnosis of CF, asthma, COPD
- Any contraindications to use of PEP e.g. severe haemoptysis, pneumothorax, recent AMI, exacerbation in the previous 4 weeks
- Inability to consent or understand English
- Cognitive impairment (MMSE&lt;24)
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>5/01/2015</anticipatedstartdate>
    <actualstartdate>9/04/2015</actualstartdate>
    <anticipatedenddate />
    <actualenddate>9/12/2016</actualenddate>
    <samplesize>39</samplesize>
    <actualsamplesize>35</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>16/12/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Prince of Wales Hospital</primarysponsorname>
    <primarysponsoraddress>61 High Street, Randwick, NSW, 2031</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Prince of Wales Hospital</fundingname>
      <fundingaddress>61 High Street, Randwick, NSW, 2031</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>University of Sydney</sponsorname>
      <sponsoraddress>Faculty of Health Sciences 
Cumberland Campus C42 
The University of Sydney 
PO Box 170 
Lidcombe NSW 1825 
AUSTRALIA</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary aim of this study is to determine the effectiveness of bubble­-PEP device compared to the active cycle of breathing technique (ACBT) or no intervention in clearing secretions in people with non­-CF bronchiectasis. The hypothesis is that the bubble­PEP is not inferior to the ACBT and is superior to no intervention in clearing secretions. Secondary aims will be to evaluate the acceptability and perceived benefits of the bubble­PEP device by participants. </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>SESLHD Human Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate>7/11/2014</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Ms</title>
      <name>Mary Santos</name>
      <address>Prince of Wales Hospital, Physiotherapy Department, 61 High Street, Randwick, NSW, 2031</address>
      <phone>+610293822671</phone>
      <fax />
      <email>mary.santos@sesiahs.health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Miss</title>
      <name>Mary Santos</name>
      <address>Prince of Wales Hospital, Physiotherapy Department, 61 High Street, Randwick, NSW, 2031</address>
      <phone>+610293822671</phone>
      <fax />
      <email>mary.santos@sesiahs.health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Mary Santos</name>
      <address>Prince of Wales Hospital, Physiotherapy Department, 61 High Street, Randwick, NSW, 2031</address>
      <phone>+610293822671</phone>
      <fax />
      <email>mary.santos@sesiahs.health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mary Santos</name>
      <address>Prince of Wales Hospital, Physiotherapy Department, 61 High Street, Randwick, NSW, 2031</address>
      <phone>+610293822671</phone>
      <fax />
      <email>shadesi2001@yahoo.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>